image
Healthcare - Biotechnology - NASDAQ - US
$ 6.7
-19.6 %
$ 715 M
Market Cap
-2.31
P/E
INCOME STATEMENT
0 REVENUE
0.00%
-273 M OPERATING INCOME
-5.22%
-259 M NET INCOME
-5.35%
EFFICIENCY
Earnings Waterfall Rocket Pharmaceuticals, Inc.
image
Revenue 0
Cost Of Revenue 0
Gross Profit 0
Operating Expenses 273 M
Operating Income -273 M
Other Expenses -14.5 M
Net Income -259 M
00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)(250m)(250m)(300m)(300m)000(273m)(273m)14m(259m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 0 7.1 6.3 5.4 1.1 0.4 0.3 0.2 0.2 45 K 0 0 0
Gross Profit 0 (7.1) (6.3) (5.4) (1.1) (0.4) (0.3) (0.2) (0.2) 45 K 0 0 0
OPERATING INCOME
Operating Expenses 273.2 259.7 223.8 166.2 134.3 75.9 71.0 26.7 41.9 20.4 7.7 6.7 5.8
Selling, General and Administrative Expenses 102.0 73.3 58.8 41.8 27.9 17.5 17.9 12.5 9.9 7.8 2.1 1.3 2.3
Research and Development Expenses 171.2 181.0 165.6 125.5 106.4 58.6 53.3 14.2 32.0 12.6 5.6 5.3 3.5
Operating Income (273.2) (259.7) (224.3) (167.2) (134.3) (76.2) (71.2) (26.7) (41.9) (20.4) (7.7) (6.7) (5.8)
PRE-TAX INCOME
Interest Income Expense 0 1.9 1.9 5.9 7.5 4.8 5.2 3.6 1.4 1.2 1.0 0.9 0.2
Total Other Income 14.5 14.1 2.5 (1.8) (5.4) (1.1) (3.4) (2.8) (1.0) (47.6) (1.8) (1.0) (0.2)
Pre-Tax Income (258.7) (245.6) (221.9) (169.1) (139.7) (77.3) (74.5) (29.5) (42.9) (68.0) (9.5) (7.6) (6.1)
NET INCOME
Tax Provision 0 0 (2.5) 0.5 7.0 6.0 2.7 0.8 0.4 1.2 0 0.9 0.2
Net Income (258.7) (245.6) (219.4) (169.6) (146.7) (83.2) (74.5) (29.5) (42.9) (68.0) (9.5) (7.6) (6.1)
EPS 2.73 2.92 3.22 2.68 2.65 1.7 1.89 4.36 6.41 14.8 2.79 3.62 2.88